Characterizing Wolf-Parkinson-White Syndrome in Africa
Clinical Profile and Current Strategies in Management of Wolf-Parkinson-White Syndrome and Asymptomatic Pre-excitation in Africa (a Multicenter WPW African Registry)
This study looks at the symptoms and treatment of people with Wolf-Parkinson-White syndrome in different African countries to better understand their experiences and outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Sex | All |
| Sponsor | Ain Shams University Academic / other |
| Locations | 1 site (Cairo, Outside US) |
| Trial ID | NCT06260384 on ClinicalTrials.gov |
What this trial studies
This observational study aims to characterize the clinical profiles of patients with Wolf-Parkinson-White (WPW) syndrome and asymptomatic WPW patterns across various African countries. It involves collecting data from patients attending outpatient cardiology clinics or referred for electrophysiological studies, focusing on their symptoms, management strategies, and ECG findings. The study will utilize a specifically designed electronic report to gather comprehensive baseline cardiovascular histories and outcomes related to both symptomatic and asymptomatic patients. Data will also be collected on the methods and success rates of interventions like radiofrequency catheter ablation.
Who should consider this trial
Good fit: Ideal candidates include patients diagnosed with a WPW pattern on ECG, whether symptomatic or asymptomatic.
Not a fit: Patients with structural heart disease or other arrhythmogenic conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the understanding and management of WPW syndrome in diverse populations, leading to better patient outcomes.
How similar studies have performed: While there have been studies on WPW syndrome, this multicenter registry approach in Africa is relatively novel and untested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients who have a preexcitation (WPW) pattern on an ECG. Exclusion Criteria: any participant who does not consent to the study. Any participants who have structural heart disease History of other arrhythmogenic diseases like Brugada syndrome, Arrhythmogenic AR dysplasia, long QT syndrome..etc Any implantable cardiac rhythm devices
Where this trial is running
Cairo, Outside US
- Ain shams university — Cairo, Outside US, Egypt (Recruiting)
Study contacts
- Principal investigator: lamyaa E Allam, MD — Ain shams university,Cairo
- Study coordinator: Lamyaa E Allam, MD
- Email: lamyaa_allam@med.asu.edu.eg
- Phone: +201004002084
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.